Details for New Drug Application (NDA): 202670
✉ Email this page to a colleague
NDA 202670 describes MITOMYCIN, which is a drug marketed by Accord Hlthcare, Eugia Pharma, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Hospira, Meitheal, and Rk Pharma, and is included in twelve NDAs. It is available from ten suppliers. Additional details are available on the MITOMYCIN profile page.
The generic ingredient in MITOMYCIN is mitomycin. There are seven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the mitomycin profile page.
The generic ingredient in MITOMYCIN is mitomycin. There are seven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the mitomycin profile page.
Pharmacology for NDA: 202670
| Mechanism of Action | Alkylating Activity |
Medical Subject Heading (MeSH) Categories for 202670
Suppliers and Packaging for NDA: 202670
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| MITOMYCIN | mitomycin | INJECTABLE;INJECTION | 202670 | ANDA | Archis Pharma LLC | 72819-152 | 72819-152-95 | 1 VIAL in 1 CARTON (72819-152-95) / 10 mL in 1 VIAL |
| MITOMYCIN | mitomycin | INJECTABLE;INJECTION | 202670 | ANDA | Archis Pharma LLC | 72819-152 | 72819-152-05 | 1 VIAL in 1 CARTON (72819-152-05) / 10 mL in 1 VIAL |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 5MG/VIAL | ||||
| Approval Date: | Oct 13, 2017 | TE: | AP | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 20MG/VIAL | ||||
| Approval Date: | Oct 13, 2017 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
